10 completed, 2 terminated. 6 Phase 1, 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 5, Terminated 1 |
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 2 |
Follow ovcon 35: new trials by email Literature Review of ovcon 35 trials Research Report on ovcon 35
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Drug Interaction Study of Danicopan Danicopan, Warfarin, Bupropion - Healthy | Phase 1 | Completed | Alexion Pharmaceuticals, Inc. | 52 | 2019-07-28 | 2021-01-14 |
| A Study of Pharmacokinetic Drug Interaction Study of the Hedgehog Pathway Inhibitor GDC-0449 in Combination With Rosiglitazone or Combined Oral Contraceptive in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy Exists Vismodegib, Rosiglitazone, Norethindrone/ethinyl estradiol - Solid Cancers | Phase 1 | Completed | Genentech, Inc. | 52 | 2010-11-01 | 2015-06-29 |
| Impact of Oral Contraceptives on GABA and Neurosteroids oral contraceptive pill (OCP; OCPs) - Healthy | Terminated | Yale University | 6 | 2008-08-01 | 2009-08-25 | |
| Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Non-Fasted Conditions Norethindrone/Ethinyl Estradiol, FEMCON® Fe - Healthy | Phase 1 | Completed | Teva Pharmaceuticals USA | 36 | 2008-08-01 | 2011-05-30 |
| A Pharmacokinetic Study of Colchicine With an Oral Contraceptive Norethindrone/Ethinyl Estradiol, Colchicine, Placebo (for Colchicine) - Pharmacokinetics | Phase 1 | Completed | Mutual Pharmaceutical Company, Inc. | 30 | 2007-08-01 | 2010-01-05 |
| Study Of Lybrel In Relation To Venous Thromboembolism 90ug levonorgestrel / 20 ug ethinyl estradiol, Oral Contraceptives containing 20 ug of ethinyl estradiol - Venous Thrombosis, Pulmonary Embolism | Completed | Pfizer | 598682 | 2007-07-01 | 2013-07-17 | |
| Study of Safety and Efficacy of an Oral Contraceptive Norethindrone/ethinyl estradiol - Contraception | Phase 3 | Completed | Warner Chilcott | 1700 | 2007-06-01 | 2013-04-22 |
| Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Fasting Conditions Norethindrone/Ethinyl Estradiol, Ovcon® 35 Fe - Bioequivalence | Phase 1 | Completed | Teva Pharmaceuticals USA | 36 | 2006-12-01 | 2011-05-25 |
| Efficacy and Safety,Long-term Study of Low-dose Oral Contraceptive Pill to Treat Dysmenorrhea. Norethindrone,Ethinyl Estradiol - Dysmenorrhea | Phase 3 | Completed | Nobelpharma | 2005-02-01 | 2010-09-10 | |
| Effect of Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Norethindrone-Ethinyl Estradiol in Healthy Female Adult Volunteers Tipranavir low dose, Tipranavir high dose, Ritonavir low dose - Healthy | Phase 1 | Terminated | Boehringer Ingelheim | 52 | 2002-05-01 | 2014-09-19 |
| Phase II Randomized Study of Leuprolide Vs Oral Contraceptive Therapy Vs Leuprolide and Oral Contraceptive Therapy for Ovarian Hyperandrogenism leuprolide, Ethinyl estradiol/norethindrone - Hyperandrogenism | Phase 2 | Completed | National Center for Research Resources (NCRR) | 45 | 1993-01-01 | 2005-06-24 |
| Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women Lopinavir/ritonavir, Ortho Novum 1/35, Ortho Evra - HIV Infections, Pregnancy | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 32 | 2021-11-01 |
Dysmenorrhea (1) · Endocrine System Diseases (1) · HIV Infections (1) · Hyperandrogenism (1) · Pulmonary Embolism (1) · Rare Diseases (1) · Sinus Thrombosis, Intracranial (1) · Venous Thrombosis (1)
Teva Pharmaceuticals USA (2) · Alexion Pharmaceuticals, Inc. (1) · Boehringer Ingelheim (1) · Genentech, Inc. (1) · Mutual Pharmaceutical Company, Inc. (1) · National Center for Research Resources (NCRR) (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Nobelpharma (1) · Pfizer (1) · Warner Chilcott (1) · Yale University (1)
United States (8) · Puerto Rico (1)
C. Neill Epperson, M.D. (1) · Dawn Colburn, Pharm.D. (1) · Herman Ellman (1) · Karen E. Elkind-Hirsch (1) · Lori Kamemoto, MD, MPH (1) · Naoki Terakawa, M.D.,Ph.D. (1)